Skip to content

Drug interactions

Alteplase + Dalteparin

Severity: Major

Alteplase and Dalteparin: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dalteparin given with alteplase increases the risk of major bleeding, including intracranial hemorrhage. Co-administration is sometimes intended, but the bleeding risk remains high.

What this interaction means in plain words

Alteplase and Dalteparin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Alteplase belongs to Cardiovascular; Dalteparin belongs to Cardiovascular.

Evidence level: High

Why it happens

Additive pharmacodynamic effect of fibrinolysis from alteplase and anti-Xa anticoagulation from dalteparin.

What to do

Co-administer only when clearly indicated and follow the protocol for dose and timing. Monitor closely for bleeding, hemoglobin and neurological status.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to see why Alteplase and Dalteparin interact, what to do about it, and the sources.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Alteplase with Dalteparin?

MediHelp rates the interaction as major. Alteplase and Dalteparin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Dalteparin given with alteplase increases the risk of major bleeding, including intracranial hemorrhage. Co-administration is sometimes intended, but the bleeding risk remains high.

How serious is the interaction between Alteplase and Dalteparin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Co-administer only when clearly indicated and follow the protocol for dose and timing. Monitor closely for bleeding, hemoglobin and neurological status.

What other medicines interact with Dalteparin?

MediHelp also lists interactions of Dalteparin with, for example, Abciximab, Acalabrutinib, Aceclofenac. The full list is on the Dalteparin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in